{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T17:16:13Z","timestamp":1788282973027,"version":"build-2803163510"},"reference-count":67,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82571202"],"award-info":[{"award-number":["82571202"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017675","name":"Chinese People\u2019s Liberation Army","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100017675","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajo.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Ophthalmology"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.ajo.2026.06.005","type":"journal-article","created":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T16:12:40Z","timestamp":1781021560000},"page":"46-60","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Optimized AAV5-RPGR ORF15 Gene Therapy Rescues Photoreceptor Structure and Function in X-Linked Retinitis Pigmentosa Mouse Model"],"prefix":"10.1016","volume":"290","author":[{"given":"Xiang","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xintong","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanshan","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-3119-8280","authenticated-orcid":false,"given":"Chunyan","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shihui","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baoke","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huanfen","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.ajo.2026.06.005_bib0001","article-title":"Retinitis pigmentosa: pathogenesis, diagnostic findings, and treatment","volume":"15","author":"Kamde","year":"2023","journal-title":"Cureus"},{"key":"10.1016\/j.ajo.2026.06.005_bib0002","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.preteyeres.2018.03.005","article-title":"Non-syndromic retinitis pigmentosa","volume":"66","author":"Verbakel","year":"2018","journal-title":"Prog Retin Eye Res"},{"issue":"1","key":"10.1016\/j.ajo.2026.06.005_bib0003","article-title":"Clinical characteristics and disease progression of retinitis pigmentosa associated with PDE6B mutations in Korean patients","volume":"10","author":"Kim","year":"2020","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.ajo.2026.06.005_bib0004","doi-asserted-by":"crossref","first-page":"e278","DOI":"10.1111\/aos.14880","article-title":"Correlation between neutrophil-to-lymphocyte ratio and clinical manifestations and complications of retinitis pigmentosa","volume":"100","author":"He","year":"2022","journal-title":"Acta Ophthalmol"},{"issue":"4","key":"10.1016\/j.ajo.2026.06.005_bib0005","doi-asserted-by":"crossref","first-page":"451","DOI":"10.4103\/aam.aam_181_22","article-title":"Clinical presentation and macular morphology in retinitis pigmentosa patients","volume":"22","author":"Okonkwo","year":"2023","journal-title":"Ann Afr Med"},{"issue":"3","key":"10.1016\/j.ajo.2026.06.005_bib0006","doi-asserted-by":"crossref","DOI":"10.1002\/mgg3.1117","article-title":"Genetic and clinical analysis in Chinese patients with retinitis pigmentosa caused by EYS mutations","volume":"8","author":"Sun","year":"2020","journal-title":"Mol Genet Genomic Med"},{"issue":"5","key":"10.1016\/j.ajo.2026.06.005_bib0007","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s11910-996-0021-z","article-title":"Retinitis pigmentosa, pigmentary retinopathies, and neurologic diseases","volume":"6","author":"Bhatti","year":"2006","journal-title":"Curr Neurol Neurosci Rep"},{"issue":"11","key":"10.1016\/j.ajo.2026.06.005_bib0008","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1016\/j.ophtha.2019.04.038","article-title":"Genetic and clinical findings in a large cohort of Chinese patients with suspected retinitis pigmentosa","volume":"126","author":"Gao","year":"2019","journal-title":"Ophthalmology"},{"issue":"2","key":"10.1016\/j.ajo.2026.06.005_bib0009","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1111\/cge.12203","article-title":"Genes and mutations causing retinitis pigmentosa","volume":"84","author":"Daiger","year":"2013","journal-title":"Clin Genet"},{"issue":"2","key":"10.1016\/j.ajo.2026.06.005_bib0010","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1001\/archopht.125.2.151","article-title":"Perspective on genes and mutations causing retinitis pigmentosa","volume":"125","author":"Daiger","year":"2007","journal-title":"Arch Ophthalmol"},{"issue":"5","key":"10.1016\/j.ajo.2026.06.005_bib0011","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1080\/13816810.2022.2109686","article-title":"Prevalence of RPGR-mutated X-linked retinitis pigmentosa among males","volume":"43","author":"Vinikoor-Imler","year":"2022","journal-title":"Ophthalmic Genet"},{"key":"10.1016\/j.ajo.2026.06.005_bib0012","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/978-3-319-95046-4_8","article-title":"X-linked retinitis pigmentosa","volume":"1085","author":"Tsang","year":"2018","journal-title":"Adv Exp Med Biol"},{"issue":"3","key":"10.1016\/j.ajo.2026.06.005_bib0013","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1038\/s41433-024-03546-8","article-title":"The burden of X-linked retinitis pigmentosa (XLRP) on patient experience and patient-reported outcomes (PROs): findings from the EXPLORE XLRP-2 study","volume":"39","author":"Parmeggiani","year":"2025","journal-title":"Eye (Lond)"},{"issue":"11","key":"10.1016\/j.ajo.2026.06.005_bib0014","doi-asserted-by":"crossref","first-page":"4434","DOI":"10.1167\/iovs.18-24555","article-title":"Development of high-throughput clinical testing of RPGR ORF15 using a large inherited retinal dystrophy cohort","volume":"59","author":"Chiang","year":"2018","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"22","key":"10.1016\/j.ajo.2026.06.005_bib0015","doi-asserted-by":"crossref","first-page":"3706","DOI":"10.1093\/hmg\/ddaa269","article-title":"RPGR isoform imbalance causes ciliary defects due to exon ORF15 mutations in X-linked retinitis pigmentosa (XLRP)","volume":"29","author":"Moreno-Leon","year":"2021","journal-title":"Hum Mol Genet"},{"issue":"4","key":"10.1016\/j.ajo.2026.06.005_bib0016","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1007\/s12041-009-0061-7","article-title":"RPGR-containing protein complexes in syndromic and non-syndromic retinal degeneration due to ciliary dysfunction","volume":"88","author":"Murga-Zamalloa","year":"2009","journal-title":"J Genet"},{"issue":"1","key":"10.1016\/j.ajo.2026.06.005_bib0017","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1038\/s41467-017-00111-8","article-title":"Gelsolin dysfunction causes photoreceptor loss in induced pluripotent cell and animal retinitis pigmentosa models","volume":"8","author":"Megaw","year":"2017","journal-title":"Nat Commun"},{"issue":"2","key":"10.1016\/j.ajo.2026.06.005_bib0018","doi-asserted-by":"crossref","first-page":"240","DOI":"10.5301\/ejo.5000879","article-title":"Novel variants of RPGR in X-linked retinitis pigmentosa families and genotype-phenotype correlation","volume":"27","author":"Parmeggiani","year":"2017","journal-title":"Eur J Ophthalmol"},{"key":"10.1016\/j.ajo.2026.06.005_bib0019","article-title":"Mutation analysis of the RPGR gene in a Chinese cohort","volume":"13","author":"Liu","year":"2022","journal-title":"Front Genet"},{"key":"10.1016\/j.ajo.2026.06.005_bib0020","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.exer.2015.06.007","article-title":"RPGR: its role in photoreceptor physiology, human disease, and future therapies","volume":"138","author":"Megaw","year":"2015","journal-title":"Exp Eye Res"},{"issue":"1","key":"10.1016\/j.ajo.2026.06.005_bib0021","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/IAE.0000000000003920","article-title":"A systematic literature review of disease progression reported in Rpgr-associated X-linked retinitis pigmentosa","volume":"44","author":"Lam","year":"2024","journal-title":"Retina"},{"key":"10.1016\/j.ajo.2026.06.005_bib0022","doi-asserted-by":"crossref","first-page":"3855","DOI":"10.2147\/OPTH.S231804","article-title":"Voretigene neparvovec in retinal diseases: a review of the current clinical evidence","volume":"14","author":"Gao","year":"2020","journal-title":"Clin Ophthalmol"},{"issue":"18","key":"10.1016\/j.ajo.2026.06.005_bib0023","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1056\/NEJMoa1706198","article-title":"Single-dose gene-replacement therapy for spinal muscular atrophy","volume":"377","author":"Mendell","year":"2017","journal-title":"N Engl J Med"},{"issue":"13","key":"10.1016\/j.ajo.2026.06.005_bib0024","first-page":"1427","article-title":"Eladocagene exuparvovec: first approval","volume":"82","author":"Keam","year":"2022","journal-title":"Drugs"},{"issue":"19","key":"10.1016\/j.ajo.2026.06.005_bib0025","doi-asserted-by":"crossref","first-page":"5179","DOI":"10.1182\/bloodadvances.2023011847","article-title":"Roctavian gene therapy for hemophilia A","volume":"8","author":"Samelson-Jones","year":"2024","journal-title":"Blood Adv"},{"issue":"7","key":"10.1016\/j.ajo.2026.06.005_bib0026","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1182\/bloodadvances.2023010511","article-title":"Hemophilia B and gene therapy: a new chapter with etranacogene dezaparvovec","volume":"8","author":"Anguela","year":"2024","journal-title":"Blood Adv"},{"issue":"6","key":"10.1016\/j.ajo.2026.06.005_bib0027","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/j.jmoldx.2016.06.007","article-title":"Improved diagnosis of inherited retinal dystrophies by high-fidelity PCR of ORF15 Followed by next-generation sequencing","volume":"18","author":"Li","year":"2016","journal-title":"J Mol Diagn"},{"issue":"1","key":"10.1016\/j.ajo.2026.06.005_bib0028","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1080\/14712598.2020.1680635","article-title":"RPGR gene therapy presents challenges in cloning the coding sequence","volume":"20","author":"Martinez-Fernandez De La Camara","year":"2020","journal-title":"Expert Opin Biol Ther"},{"key":"10.1016\/j.ajo.2026.06.005_bib0029","doi-asserted-by":"crossref","first-page":"991","DOI":"10.3389\/fnins.2019.00991","article-title":"Retinal phenotype in the rd9 mutant mouse, a model of X-linked RP","volume":"13","author":"Falasconi","year":"2019","journal-title":"Front Neurosci"},{"issue":"4","key":"10.1016\/j.ajo.2026.06.005_bib0030","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1089\/humc.2018.168","article-title":"Toxicology and pharmacology of an AAV vector expressing codon-optimized RPGR in RPGR-deficient Rd9 mice","volume":"29","author":"Song","year":"2018","journal-title":"Hum Gene Ther Clin Dev"},{"issue":"4","key":"10.1016\/j.ajo.2026.06.005_bib0031","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1167\/iovs.61.4.31","article-title":"In vivo CRISPR\/Cas9-mediated genome editing mitigates photoreceptor degeneration in a mouse model of X-linked retinitis pigmentosa","volume":"61","author":"Hu","year":"2020","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"49","key":"10.1016\/j.ajo.2026.06.005_bib0032","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2208707119","article-title":"Impaired glutamylation of RPGRORF15 underlies the cone-dominated phenotype associated with truncating distal ORF15 variants","volume":"119","author":"Cehajic-Kapetanovic","year":"2022","journal-title":"Proc Natl Acad Sci USA"},{"issue":"21","key":"10.1016\/j.ajo.2026.06.005_bib0033","doi-asserted-by":"crossref","first-page":"E2925","DOI":"10.1073\/pnas.1523201113","article-title":"Loss of RPGR glutamylation underlies the pathogenic mechanism of retinal dystrophy caused by TTLL5 mutations","volume":"113","author":"Sun","year":"2016","journal-title":"Proc Natl Acad Sci USA"},{"issue":"4","key":"10.1016\/j.ajo.2026.06.005_bib0034","doi-asserted-by":"crossref","first-page":"276","DOI":"10.4103\/sjopt.sjopt_168_23","article-title":"Retinitis pigmentosa GTPase regulator-related retinopathy and gene therapy","volume":"37","author":"Wongchaisuwat","year":"2023","journal-title":"Saudi J Ophthalmol"},{"key":"10.1016\/j.ajo.2026.06.005_bib0035","doi-asserted-by":"crossref","first-page":"49","DOI":"10.63500\/mv_v30_49","article-title":"Clinical sequencing of the retinitis pigmentosa gene RPGR in over 1,000 cases of vision loss","volume":"30","author":"Pantrangi","year":"2024","journal-title":"Mol Vis"},{"key":"10.1016\/j.ajo.2026.06.005_bib0036","doi-asserted-by":"crossref","DOI":"10.1016\/j.preteyeres.2020.100898","article-title":"The X-linked retinopathies: physiological insights, pathogenic mechanisms, phenotypic features and novel therapies","volume":"82","author":"De Silva","year":"2021","journal-title":"Prog Retin Eye Res"},{"key":"10.1016\/j.ajo.2026.06.005_bib0037","doi-asserted-by":"crossref","first-page":"308","DOI":"10.3389\/fgene.2019.00308","article-title":"661W Photoreceptor cell line as a cell model for studying retinal ciliopathies","volume":"10","author":"Wheway","year":"2019","journal-title":"Front Genet"},{"key":"10.1016\/j.ajo.2026.06.005_bib0038","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.gde.2019.05.004","article-title":"The photoreceptor cilium and its diseases","volume":"56","author":"Bachmann-Gagescu","year":"2019","journal-title":"Curr Opin Genet Dev"},{"issue":"8","key":"10.1016\/j.ajo.2026.06.005_bib0039","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1089\/hum.2018.244","article-title":"Development of a molecularly stable gene therapy vector for the treatment of RPGR-associated X-linked retinitis pigmentosa","volume":"30","author":"Giacalone","year":"2019","journal-title":"Hum Gene Ther"},{"issue":"14","key":"10.1016\/j.ajo.2026.06.005_bib0040","doi-asserted-by":"crossref","first-page":"3956","DOI":"10.1093\/hmg\/ddv134","article-title":"A long-term efficacy study of gene replacement therapy for RPGR-associated retinal degeneration","volume":"24","author":"Wu","year":"2015","journal-title":"Hum Mol Genet"},{"issue":"8","key":"10.1016\/j.ajo.2026.06.005_bib0041","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1016\/j.ymthe.2017.05.005","article-title":"Codon-optimized RPGR improves stability and efficacy of AAV8 gene therapy in two mouse models of X-linked retinitis pigmentosa","volume":"25","author":"Fischer","year":"2017","journal-title":"Mol Ther"},{"issue":"3","key":"10.1016\/j.ajo.2026.06.005_bib0042","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.3390\/ijms25031839","article-title":"AAV-RPGR gene therapy rescues opsin mislocalisation in a human retinal organoid model of RPGR-associated X-linked retinitis pigmentosa","volume":"25","author":"Sladen","year":"2024","journal-title":"Int J Mol Sci"},{"issue":"8","key":"10.1016\/j.ajo.2026.06.005_bib0043","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1016\/j.ymthe.2017.05.004","article-title":"Optimization of retinal gene therapy for X-linked retinitis pigmentosa due to RPGR mutations","volume":"25","author":"Beltran","year":"2017","journal-title":"Mol Ther"},{"issue":"2","key":"10.1016\/j.ajo.2026.06.005_bib0044","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1038\/gt.2015.93","article-title":"Photoreceptor rescue by an abbreviated human RPGR gene in a murine model of X-linked retinitis pigmentosa","volume":"23","author":"Pawlyk","year":"2016","journal-title":"Gene Ther"},{"issue":"1","key":"10.1016\/j.ajo.2026.06.005_bib0045","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.exer.2006.03.006","article-title":"Focus on molecules: RPGR","volume":"85","author":"Wright","year":"2007","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.ajo.2026.06.005_bib0046","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/414781","article-title":"The role of RPGR and its interacting proteins in ciliopathies","volume":"2015","author":"Patnaik","year":"2015","journal-title":"J Ophthalmol"},{"issue":"6","key":"10.1016\/j.ajo.2026.06.005_bib0047","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.15252\/embr.201643751","article-title":"Molecular interactions between tubulin tails and glutamylases reveal determinants of glutamylation patterns","volume":"18","author":"Natarajan","year":"2017","journal-title":"EMBO Rep"},{"issue":"5","key":"10.1016\/j.ajo.2026.06.005_bib0048","doi-asserted-by":"crossref","first-page":"2775","DOI":"10.1167\/iovs.10-6250","article-title":"Intravitreal injection of AAV2 transduces macaque inner retina","volume":"52","author":"Yin","year":"2011","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ajo.2026.06.005_bib0049","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.omtm.2020.01.002","article-title":"Suprachoroidal and subretinal injections of AAV using transscleral microneedles for retinal gene delivery in nonhuman primates","volume":"16","author":"Yiu","year":"2020","journal-title":"Mol Ther Methods Clin Dev"},{"issue":"2","key":"10.1016\/j.ajo.2026.06.005_bib0050","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1038\/mt.2010.230","article-title":"Inhibition of choroidal neovascularization in a nonhuman primate model by intravitreal administration of an AAV2 vector expressing a novel anti-VEGF molecule","volume":"19","author":"Lukason","year":"2011","journal-title":"Mol Ther"},{"issue":"7","key":"10.1016\/j.ajo.2026.06.005_bib0051","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1167\/tvst.9.7.28","article-title":"Trans-ocular electric current in vivo enhances AAV-mediated retinal transduction in large animal eye after intravitreal vector administration","volume":"9","author":"Song","year":"2020","journal-title":"Transl Vis Sci Technol"},{"issue":"3","key":"10.1016\/j.ajo.2026.06.005_bib0052","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.visres.2007.08.009","article-title":"Comparative analysis of in vivo and in vitro AAV vector transduction in the neonatal mouse retina: effects of serotype and site of administration","volume":"48","author":"Pang","year":"2008","journal-title":"Vision Res"},{"issue":"10","key":"10.1016\/j.ajo.2026.06.005_bib0053","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1089\/hum.2012.125","article-title":"The human rhodopsin kinase promoter in an AAV5 vector confers rod- and cone-specific expression in the primate retina","volume":"23","author":"Boye","year":"2012","journal-title":"Hum Gene Ther"},{"issue":"20","key":"10.1016\/j.ajo.2026.06.005_bib0054","doi-asserted-by":"crossref","first-page":"11372","DOI":"10.1128\/JVI.01327-07","article-title":"Novel adeno-associated virus serotypes efficiently transduce murine photoreceptors","volume":"81","author":"Allocca","year":"2007","journal-title":"J Virol"},{"issue":"26","key":"10.1016\/j.ajo.2026.06.005_bib0055","doi-asserted-by":"crossref","first-page":"3075","DOI":"10.1093\/hmg\/10.26.3075","article-title":"Exchange of surface proteins impacts on viral vector cellular specificity and transduction characteristics: the retina as a model","volume":"10","author":"Auricchio","year":"2001","journal-title":"Hum Mol Genet"},{"issue":"2","key":"10.1016\/j.ajo.2026.06.005_bib0056","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/mt.2013.232","article-title":"Successful gene therapy in the RPGRIP1-deficient dog: a large model of cone-rod dystrophy","volume":"22","author":"Lh\u00e9riteau","year":"2014","journal-title":"Mol Ther"},{"issue":"7","key":"10.1016\/j.ajo.2026.06.005_bib0057","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1038\/gt.2011.3","article-title":"AAV-mediated photoreceptor transduction of the pig cone-enriched retina","volume":"18","author":"Mussolino","year":"2011","journal-title":"Gene Ther"},{"issue":"9","key":"10.1016\/j.ajo.2026.06.005_bib0058","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1038\/gt.2010.56","article-title":"rAAV2\/5 gene-targeting to rods: dose-dependent efficiency and complications associated with different promoters","volume":"17","author":"Beltran","year":"2010","journal-title":"Gene Ther"},{"issue":"14","key":"10.1016\/j.ajo.2026.06.005_bib0059","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1038\/gt.2008.32","article-title":"Targeting gene expression to cones with human cone opsin promoters in recombinant AAV","volume":"15","author":"Kom\u00e1romy","year":"2008","journal-title":"Gene Ther"},{"issue":"8","key":"10.1016\/j.ajo.2026.06.005_bib0060","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1089\/hum.2009.218","article-title":"Replacement gene therapy with a human RPGRIP1 sequence slows photoreceptor degeneration in a murine model of Leber congenital amaurosis","volume":"21","author":"Pawlyk","year":"2010","journal-title":"Hum Gene Ther"},{"key":"10.1016\/j.ajo.2026.06.005_bib0061","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.ajo.2024.05.034","article-title":"Phase 1\/2 AAV5-hRKp.RPGR (botaretigene sparoparvovec) gene therapy: safety and efficacy in RPGR-associated X-linked retinitis pigmentosa","volume":"267","author":"Michaelides","year":"2024","journal-title":"Am J Ophthalmol"},{"issue":"9","key":"10.1016\/j.ajo.2026.06.005_bib0062","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/j.ophtha.2024.02.023","article-title":"Assessment of visual function with cotoretigene toliparvovec in X-linked retinitis pigmentosa in the randomized XIRIUS phase 2\/3 study","volume":"131","author":"Lam","year":"2024","journal-title":"Ophthalmology"},{"issue":"10","key":"10.1016\/j.ajo.2026.06.005_bib0063","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1089\/hum.2019.143","article-title":"Prevalence and relevance of pre-existing anti-adeno-associated virus immunity in the context of gene therapy for Crigler-Najjar syndrome","volume":"30","author":"Aronson","year":"2019","journal-title":"Hum Gene Ther"},{"issue":"7-8","key":"10.1016\/j.ajo.2026.06.005_bib0064","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1089\/hum.2021.287","article-title":"Global seroprevalence of pre-existing immunity against AAV5 and other AAV serotypes in people with hemophilia A","volume":"33","author":"Klamroth","year":"2022","journal-title":"Hum Gene Ther"},{"issue":"7","key":"10.1016\/j.ajo.2026.06.005_bib0065","doi-asserted-by":"crossref","first-page":"3649","DOI":"10.1073\/pnas.97.7.3649","article-title":"A retinitis pigmentosa GTPase regulator (RPGR)-deficient mouse model for X-linked retinitis pigmentosa (RP3)","volume":"97","author":"Hong","year":"2000","journal-title":"Proc Natl Acad Sci USA"},{"issue":"5","key":"10.1016\/j.ajo.2026.06.005_bib0066","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0035865","article-title":"Rd9 is a naturally occurring mouse model of a common form of retinitis pigmentosa caused by mutations in RPGR-ORF15","volume":"7","author":"Thompson","year":"2012","journal-title":"PLoS One"},{"issue":"11","key":"10.1016\/j.ajo.2026.06.005_bib0067","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a041280","article-title":"RPGR-related retinopathy: clinical features, molecular genetics, and gene replacement therapy","volume":"13","author":"Awadh Hashem","year":"2023","journal-title":"Cold Spring Harb Perspect Med"}],"container-title":["American Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000293942600303X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000293942600303X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T16:31:25Z","timestamp":1788280285000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000293942600303X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":67,"alternative-id":["S000293942600303X"],"URL":"https:\/\/doi.org\/10.1016\/j.ajo.2026.06.005","relation":{},"ISSN":["0002-9394"],"issn-type":[{"value":"0002-9394","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Optimized AAV5-RPGR ORF15 Gene Therapy Rescues Photoreceptor Structure and Function in X-Linked Retinitis Pigmentosa Mouse Model","name":"articletitle","label":"Article Title"},{"value":"American Journal of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajo.2026.06.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}